UMC Utrecht receives grants for research into post-COVID

A total of 21 new studies have been launched in the Netherlands, focusing on biomedical and clinical research on post-COVID. UMC Utrecht’s four projects are part of a broader grant program totaling 16.4 million euros aimed at gaining more knowledge about post-COVID. This research is of major importance because it can contribute to better treatments for the thousands of people who struggle daily with the consequences of COVID-19. The honored projects are carried out in collaboration with other research institutions and patient organizations, so that the concerns and needs of patients are always the focus.

• Recovery after exercise: How does extreme fatigue occur?
  One of the projects, led by Fred Hartgens (Department of Sports Medicine), professor of Clinical Sports Medicine, specifically addresses the symptoms that many post-COVID patients experience after physical exertion, such as extreme fatigue and pain. This is called ‘post-exertional malaise’ (PEM). The research team will use advanced diagnostic methods, such as heart rate variability and oxygen uptake using near-infrared spectroscopy, to better understand how these symptoms arise and the physiological processes behind them. The goal is to help patients better manage their energy so they can safely resume daily activities.
• Post-COVID and the immune system: what exactly happens? 
  Leo Koenderman (Center for Translational Immunology), professor of Experimental Lung Diseases, focuses on the severe forms of post-COVID. Some patients cannot even come to a hospital because of the severity of their symptoms. This research looks at the role of the immune system and metabolism in the development of post-COVID. By using mobile diagnostic equipment, the team aims to identify symptoms of severe post-COVID and PEM. This may eventually lead to the identification of objective disease markers that will help physicians diagnose and develop treatments.
• Post-COVID in children: An understudied problem
  Post-COVID is not only a problem for adults; it can also affect children. The research led by Niels Eijkelkamp (Center for Translational Immunology), professor of Neuro-Immunology of Pain, focuses on children with post-COVID, a condition that is often difficult to recognize and treat. Little is known about the biomedical causes of post-COVID in children. Among other things, the research team will analyze blood samples to look for signs of inflammation in the brain or changes in the immune system. The goal is to develop better diagnostic tools and treatment options specifically for children, who are at a different stage of development than adults.
• New drugs for post-COVID: Minocycline as a possible solution
  Another promising project, led by Janneke van de Wijgert (Julius Center for Health Sciences and Primary Care), professor of Epidemiology of Infectious and Immune-Mediated Diseases, will investigate whether existing drugs originally developed for other conditions could help treat post-COVID symptoms. Minocycline, a drug that inhibits inflammation, is being compared to a placebo. This is part of a larger study of ‘repurposed drugs’, drugs that are approved for other conditions but may also be effective in treating post-COVID.

With these four major research initiatives, UMC Utrecht hopes to contribute to the scientific breakthrough needed to better understand and effectively treat post-COVID.